Pulmatrix Appoints Respiratory and Allergy Expert, Michael Yeadon, PhD, to Scientific Advisory Board
LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory ...
Two years after Michael Yeadon and a close-knit group of Pfizer investigators managed to grab some of the pharma giant's ($PFE) anti-inflammatory assets on the way ...
Contrary to a claim made by ex-Pfizer scientist Michael Yeadon, there’s no evidence to say COVID-19 vaccines are “50 times more likely” to kill children than COVID-19 itself. Contacted by Reuters, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback